Our CRISPR screening approach was successful in identifying robust modulators of insulin content, as shown through the detection of not only the insulin gene itself but also genes involved in monogenic types of diabetes or known regulators of insulin transcription and secretion. This evidence concerns the gene INS and diabetes mellitus.